Sangeetha Iyer

Sangeetha Iyer currently serves as the Director of Alliance and Portfolio Management at BigHat Biosciences since February 2024 and has held the position of Scientific Advisor for the Association for Creatine Deficiencies since September 2019. Previously, Sangeetha worked as a Senior Manager in Program Management at Pfizer's Emerging Sciences and Innovation Unit from March 2021 to February 2024, overseeing project value delivery. Sangeetha also contributed as a Senior Scientist at Denali Therapeutics and as the Director of Preclinical Development at Perlara PBC, where Sangeetha was pivotal in advancing orphan drugs into clinical trials. With a foundation in neurodegenerative disorders and rare genetic diseases, Sangeetha's academic credentials include a PhD in Molecular Pharmacology from the University of Pittsburgh School of Medicine and a Bachelor of Science in Pharmaceutical Sciences from the Institute of Chemical Technology.